Fundraising Fox

Biotech Investors & VC Firms in United States

564 firms in this list, with a median first check of $500K. 46 of them lead rounds. Generated from verified public data and updated continuously.

TCG Crossover
Palo AltoSeed–Late Stage
8 people
BioRock Ventures
Bay AreaSeed–Late Stage
1 person
Aditum Bio
OaklandSeries A–Series B
+ND Capital
WoodsideSeed–Late Stage$540K – $5.4M
5 people
AMR Action Fund
BostonSeed–Series B
8 people
Camford Capital
Menlo ParkPre-Seed–Series A
8 people
Co-Win Ventures
SuzhouSeed–Series B
8 people
Debiopharm Innovation Fund
LausanneSeries A–Late Stage$3M – $5M
5 people
Fast Track Initiative
TokyoSeed–Growth
8 people
Innovation Nest
KrakowSeed–Series A$108K – $1.1M
5 people
MassVentures
WalthamSeed–Late Stage$250K – $500K
5 people
MSD Global Health Innovation Fund
RahwaySeries A–Late Stage$1M – $30M
5 people
Sectoral Asset Management
MontrealSeries A–Late Stage
8 people
Shoreline Venture Management
San FranciscoSeed–Series A$250K – $1M
5 people
The Engine Ventures
CambridgeSeed–Series A
8 people
Trans-Pacific Technology Fund
TaipeiSeed–Late Stage
8 people
Ambix Venture Management, Llc
Mountain ViewPre-Seed–Late Stage
2 people
AIX Ventures
San FranciscoPre-Seed–Series A$1M – $5M
4 people
Astellas Venture Management LLC
South San FranciscoSeed–Series B$200K – $5M
4 people
Biomark Capital
GreenwichSeries A–Late Stage$5M – $10M
4 people
Brunnur Ventures GP
ReykjavíkSeed–Series A$1M – $3M
4 people
Curie.Bio
BostonSeed–Series A$7M
7 people
Delos Capital
CambridgeSeed–Late Stage
7 people
Expara
Seed–Series A
7 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.